[PLX] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -30.90%
YoY- -39.38%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 4,616 5,097 1,384 3,707 2,686 7,383 1,122 157.41%
PBT -5,071 -5,972 -8,469 -8,010 -6,119 -7,345 -10,885 -39.98%
Tax 43 28 57 49 202 38 0 -
NP -5,071 -5,972 -8,469 -8,010 -6,119 -7,345 -10,885 -39.98%
Tax Rate - - - - - - - -
Total Cost 9,687 11,069 9,853 11,717 8,805 14,728 12,007 -13.37%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin -109.86 -117.17 -611.92 -216.08 -227.81 -99.49 -970.14 -76.68%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS -0.05 -0.06 -0.91 -0.09 -0.07 -0.08 -1.18 -87.91%
EPS Diluted -0.05 -0.06 -0.91 -0.09 -0.07 -0.08 -1.17 -87.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.